SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-016930
Filing Date
2019-11-12
Accepted
2019-11-12 16:51:34
Documents
85
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 1049948
2 ex10-1.htm EX-10.1 6631
3 ex10-2.htm EX-10.2 44694
4 ex31-1.htm EX-31.1 17546
5 ex31-2.htm EX-31.2 17551
6 ex32-1.htm EX-32.1 8796
  Complete submission text file 0001493152-19-016930.txt   6771021

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE lctx-20190930.xml EX-101.INS 1257525
8 XBRL SCHEMA FILE lctx-20190930.xsd EX-101.SCH 79991
9 XBRL CALCULATION FILE lctx-20190930_cal.xml EX-101.CAL 93654
10 XBRL DEFINITION FILE lctx-20190930_def.xml EX-101.DEF 421333
11 XBRL LABEL FILE lctx-20190930_lab.xml EX-101.LAB 535741
12 XBRL PRESENTATION FILE lctx-20190930_pre.xml EX-101.PRE 461072
Mailing Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008 5105213390
Lineage Cell Therapeutics, Inc. (Filer) CIK: 0000876343 (see all company filings)

IRS No.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12830 | Film No.: 191210419
SIC: 2836 Biological Products, (No Diagnostic Substances)